Across TCGA pan-cancer cohorts, IFNE Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated IFNE data layer compared with 23 for mass-spec protein.

The strongest signal is observed in sarcoma (SARC), where higher IFNE Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated IFNE expression acts as an unfavorable survival marker.

SARC and SKCM are the cancer types where IFNE Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SARC	OS	Median	All	0.029	0.828	<.001	6	view →
SKCM	DFS	Median	All	0.226	0.757	.037	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: IFNE tumor-vs-normal RNA expression · all IFNE data types